Evidence map›Paper›PMID 34310048›Full record

ReviewSmall (Weinheim an der Bergstrasse, Germany)2021

Micro and Nanoscale Technologies for Diagnosis of Viral Infections.

Fatemeh Nasrollahi, Reihaneh Haghniaz, Vahid Hosseini, Elham Davoodi, Mahboobeh Mahmoodi, Solmaz Karamikamkar, Mohammad Ali Darabi, Yangzhi Zhu, Junmin Lee, Sibel Emir Diltemiz and 8 more

Open access · hybridAbstract readReview
In one paragraph

Review in Small (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. An All-In-One Transient Theranostic Platform for Intelligent Management of Hemorrhage.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Self-adjuvanting cancer nanovaccines.Journal of nanobiotechnology · 2022
    Review
  12. Advances in the Rapid Diagnostic of Viral Respiratory Tract Infections.Frontiers in cellular and infection microbiology · 2022
    Review
  13. Micro and Nanoscale Technologies for Diagnosis of Viral Infections.Small (Weinheim an der Bergstrasse, Germany) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 4 countries.

Fatemeh NasrollahiTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Reihaneh HaghniazTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Vahid HosseiniTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Elham DavoodiTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Mahboobeh MahmoodiDepartment of Bioengineering, University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Solmaz KaramikamkarTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Mohammad Ali DarabiTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Yangzhi ZhuTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Junmin LeeTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Sibel Emir DiltemizDepartment of Bioengineering, University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Hossein MontazerianTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Sivakoti SangabathuniTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Maryam TavafoghiDepartment of Bioengineering, University of California-Los Angeles, Los Angeles, CA, 90095, USA.
Vadim JucaudTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Wujin SunTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Han-Jun KimTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Samad AhadianTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.
Ali KhademhosseiniTerasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA, 90024, USA.ORCID https://orcid.org/0000-0002-2692-1524
Terasaki Foundation · USUniversity of California, Los Angeles · USUniversity of Waterloo · CA

Funding

Fulbright-Nehru Postdoctoral Fellowship 2395/FNPDR/2018SNF Postdoctoral Fellowship P2EZP2_187980
6 · The paper itself

Abstract

Viral infection is one of the leading causes of mortality worldwide. The growth of globalization significantly increases the risk of virus spreading, making it a global threat to future public health. In particular, the ongoing coronavirus disease 2019 (COVID-19) pandemic outbreak emphasizes the importance of devices and methods for rapid, sensitive, and cost-effective diagnosis of viral infections in the early stages by which their quick and global spread can be controlled. Micro and nanoscale technologies have attracted tremendous attention in recent years for a variety of medical and biological applications, especially in developing diagnostic platforms for rapid and accurate detection of viral diseases. This review addresses advances of microneedles, microchip-based integrated platforms, and nano- and microparticles for sampling, sample processing, enrichment, amplification, and detection of viral particles and antigens related to the diagnosis of viral diseases. Additionally, methods for the fabrication of microchip-based devices and commercially used devices are described. Finally, challenges and prospects on the development of micro and nanotechnologies for the early diagnosis of viral diseases are highlighted.

Indexed as

COVID-19Virus DiseasesHumansNanotechnologyPandemicsSARS-CoV-2COVID-19diagnosismicro and nanoscale technologiesmicrochipsmicrofluidic devicesnanoparticlesviral infection

Identifiers

PMID34310048
PMCPMC8420309
OpenAlexW3184086826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.